The China Aneurysm Interventional landscape, Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future Outlook (2021- 2026)

October 2022
The China Aneurysm report is the first-ever syndicated report that covers the market landscape, procedural and technology trends, and competitive intelligence. The report is based on exhaustive secondary research and in-depth primary research conducted with performing physicians in Interventional Radiology, Neurosurgery and Interventional Neurology departments from level 2 and level 3 hospitals in China.

The report covers:

  • Aneurysm procedures: aortic and cerebral aneurysm procedures.
  • Interventional devices: coils, occlusion balloon systems, catheters, pipeline embolization devices, aortic stent grafts, and guidewires
  • Procedure trends: stages of the disease, aneurysm location, performing departments, route of access used for the intervention, and type of interventions


  • Insights on hospital structure and utilization, physician treatment selection criteria, current and upcoming policies for diagnosis and treatment, and payer coverage are delved into.
  • Physicians’ brand perception and their rank of medical device companies based on 15 KPIs such as technology, clinical evidence, patient outcome, etc. Moreover, diligent examination of physician’s brand usage and brand satisfaction levels, and the factors such as ease of use of the device, and cost-effectiveness among others effecting brand usage have been covered.
  • Future trends such as development of deep learning-based algorithms for the detection of potentially life-threatening aneurysms on CT angiography images for enhanced detection and early diagnosis are covered. The report highlights the successful completion of the world’s first robotic-assisted endovascular minimally invasive treatment for a thoracic and abdominal aortic aneurysm which uses a humanoid multi-manipulator design to mimic the hand movements of doctors and their assistants while adapting to the requirements of various interventional procedures.
  • Competitor landscape covers market events such as emerging companies, product approvals, clinical trials, partnerships etc. Competitor activities such as NMPA approval of NUMEN Silk 3-D Coil Embolization System MicroPort NeuroTech are covered in the report.
  • This report will help Aneurysm disease interventional device companies understand the aneurysm landscape, procedural and technology trends, the brand perception, in China.
  • The report is a great resource to plan your market strategy to capitalize on upcoming trends and potential disruptors in the Aneurysm disease devices market.
The deliverable includes a 100+ slide MS PowerPoint report and an MS Excel-based 5-Year market forecast model.
Contact us for further details regarding the exclusive data and insights in the report or for an exploratory analyst walkthrough of the report.

    Drop Us A Line

    We provide the best insights for your business